DZ-837

DZ-837 is a BCL6-targeting PROTAC molecule composed of a BCL6 ligand, a thalidomide-based E3 ligase binder, and a linker. Its structure includes the conjugate 2- (2,6-Dioxopiperidin-3-yl) -4- ((2- (2-hydroxyethoxy) ethyl) amino) isoindoline-1,3-dione. This compound is a research tool for studying BCL6 degradation and its roles in oncology and immunology through in vitro and in vivo experiments.